US 9624306
Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer
granted A61KA61K2039/505A61K2239/31
Quick answer
US patent 9624306 (Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2039/505, A61K2239/31, A61K2239/38, A61K2239/47